Anti-histone antibodies

Anti-histone antibodies jẹ́ àwọn èròjà ìdáàbòbò ara tí ara má ń ṣètò rẹ̀ tí wọ́n sì maa ń ri ní ìdá àádọ́ta (50%) sí ìdá àádọ́rin (70%) àwọn aláìsàn tí wọ́n ní àrùn systemic lupus erythematosus (SLE) àti àwọn tí ó ju 95% àwọn aláìsàn tí wọ́n ní àrùn drug-induced lupus erythematosus.^[1]

ELISA tí wọ́n fi ń ṣe ìwádí anti-histone antibodies maa sọọ́ di mímọ̀ wípé ó wà lára tí ó bá rí ju 25 units/ml anti-histone antibodies nínú ẹ̀jẹ̀.^[2]

Àwọn ìtọ́ka sí

↑ Table 5-9 in: Mitchell, Richard Sheppard; Kumar, Vinay; Abbas, Abul K.; Fausto, Nelson (2007). Robbins Basic Pathology. Philadelphia: Saunders. ISBN 1-4160-2973-7.
↑ chronolab.com > Autoantibodies associated with rheumatic diseases > Reference ranges Archived 2013-07-30 at the Wayback Machine. Retrieved on April 29, 2010

[Kumar5-9-1] Table 5-9 in: Mitchell, Richard Sheppard; Kumar, Vinay; Abbas, Abul K.; Fausto, Nelson (2007). Robbins Basic Pathology. Philadelphia: Saunders. ISBN 1-4160-2973-7.

[chronolab-2] ronolab.com > Autoantibodies associated with rheumatic diseases > Reference ranges Archived 2013-07-30 at the Wayback Machine. Retrieved on April 29, 2010

[1]

[2]